Filing Details
- Accession Number:
- 0000784199-18-000183
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-09-04 18:59:52
- Reporting Period:
- 2018-08-30
- Accepted Time:
- 2018-09-04 18:59:52
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
784199 | Cryolife Inc | CRY | Surgical & Medical Instruments & Apparatus (3841) | 592417093 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1409753 | B Scott Capps | Cryolife, Inc. 1655 Roberts Blvd, Nw Kennesaw GA 30144 | Vp, Clinical Research | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-08-30 | 8,332 | $5.67 | 147,419 | No | 4 | M | Direct | |
Common Stock | Disposition | 2018-08-30 | 6,332 | $34.10 | 141,087 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2018-08-30 | 8,332 | $5.67 | 8,332 | $5.67 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2013-02-18 | 2019-02-18 | No | 4 | M | Direct |
Footnotes
- Reflects weighted average price. Range was from $34.10 to $34.15. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
- Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 2/18/2013